Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma

Cancer Letters

Volumn 111, Issue 1-2, 1997, Pages 127-131

  Kozma, László ^a   Kiss, István ^b   Nagy, Attila ^a   Szakáll, Szabolcs ^a   Ember, István ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Amplification; c myc; K ras; Progression; Renal clear cell adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DOT HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MALE; ONCOGENE C MYC; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; GENE AMPLIFICATION; GENES, MYC; GENES, RAS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 0031023602     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04527-2     Document Type: Article

References (30)

1. Brison, O. (1993) Gene amplification and tumor progression, Biochim. Biophys. Acta, 1155, 25-41.
2. Kozma, L., Kiss, I.. Szakall, Sz. and Ember, I. (1994) Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett., 81, 165-169.
3. Varley, J.M., Swallow, J.E., Brammar, W.J., Whittaker, J.L. and Walker, R.A. (1987) Alterations to either c-erbB2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with short-term prognosis, Oncogene, 1, 423-430.
4. Harnevo, L.E. and Agur, Z. (1993) Use of mathematical models for understanding the dynamics of gene amplification, Mutat. Res., 292, 17-24.
5. Uchida, T., Wada, C., Wang, C., Egawa, S., Ohtani, H. and Koshiba, K. (1994) Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma, Cancer Res., 54, 3682-3685.
6. Heerdt, B.G., Molinas, S., Deitch, D. and Augenlicht, L.H. (1991) Aggressive subtypes of human colorectal tumours frequently exhibit amplification of the c-myc gene, Oncogene, 6, 125-129.
7. Seeger, R.C., Brodeur, G.M. and Sather, H. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N. Engl. J. Med., 313, 1111-1116.
8. Fan, Q.B., Bian, M.L., Huang, S.Z., Lang, J.H., Ma, J., Liu, W.S. and Xu, X.Y. (1994) Amplification of the c-erbB2 (HER2/neu) proto-oncogene in ovarian carcinomas. Chin. Med. J., 107, 589-593.
9. Volm, M., Drings, P., Wodrich, W. and van Kaick, G. (1993) Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastasis, Clin. Exp. Metastasis, 11, 325-329.
10. Rotter, M., Block, T., Busch, R., Thanner, S. and Hofler, H. (1992) Expression of HER-2/neu in renal cell carcinoma. Correlation with histologie subtypes and differentiation, Int. J. Cancer, 52, 213-217.
11. Weidner, U., Peter, S., Strohmeyer. T., Hussnatter, R., Ackermann, R. and Sies, H. (1990) Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma, Cancer Res., 50, 4504-4509.
12. Lunec, J., Challen, C., Wright, C, Mellon, K. and Neal, D.E. (1992) C-erbB2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder (letter), Lancet, 339, 439-440.
13. Kataoka, A., Yakushiji, M., Ohbuchi, T., Morimitsu, Y. and Kojiro, M. (1991) Characterization of oncogenes (K, N-ras and N, c-myc) in subcloned cell lines (KCC-1a and 1b) derived from same endometrial carcinoma presenting well differentiated adenocarcinoma and clear cell carcinoma, Nippon Sanka Fujinka Gakkai Zasshi, 43, 1317-1322.
14. Yao, M., Shuin, T.. Misaki, H. and Kubota, Y. (1988) Enhanced expression of c-myc and epidermal growth factor receptor (c-erbB-1) genes in primary human renal cancer. Cancer Res., 48, 6753-6757.
15. Ohgaki, H., Kleihues, P. and Hard, G.C. (1991) Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat, Mol. Carcinogenesis, 4, 455-459.
16. Goelz. S.E., Hamilton, S.R. and Vogelstein, B. (1985) Purification of DNA from formaldehyde fixed and paraffin embedded human tissue, Biochem. Biophys. Res. Commun., 130, 118-126.
17. Nishikura, K., Ar-Rushdi, A., Erikson, J., Watt, R., Rovera, G. and Croce, C.M. (1983) Differential expression of the normal and of the translocated human c-myc oncogenes in B cells, Proc. Natl. Acad. Sci. USA, 80, 4822-4826.
18. McCoy, M.S., Toole, J.J., Cunningham, J.M.. Chang, E.H., Lowy, D.R. and Weinberg, R.A. (1983) Characterization of a human colon/lung carcinoma oncogene. Nature, 302, 79-81.
19. Gerharz, C.D., Ramp, U., Olert, J., Moll, R., Storkel, S., Marx, N. and Gabbert, H.E. (1994) Cytomorphological, cytogenetic and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type, Virchows Arch., 424, 403-409.
20. Salhab, N., Jones, D.J., Bos, J.L., Kinsella, A. and Schofield, P.F. (1989) Detection of ras gene alterations and ras proteins in colorectal cancer, Dis. Colon Rectum, 32, 659-664.
21. Ambros, R.A. (1992) C-myc gene expression in stage I endometrioid adenocarcinoma of the uterus, Mat. Med. Pol., 24, 76-78.
22. Kobayashi, T., Tsuda, H., Noguchi, M., Hirohashi, S., Shimosato, Y., Goya, T. and Hayata, Y. (1990) Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologie subtypes, Cancer, 66, 289-294.
23. Czerniak, B., Chen, R., Tuziak, T., Markiewski, M., Kram, A., Gorczyca, W., Deitch, D., Herz, F. and Koss, L.G. (1989) Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas, Cancer, 63, 2008-2013.
24. Minamoto, T., Sawaguchi, K., Mai, M., Yamashita, N., Sugimura, T. and Esumi, H. (1994) Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas, Cancer Res., 54, 2841-2844.
25. Agnantis, N.J., Apostolikas, N.A., Zolotas, V.G. and Spandidos, D.A. (1994) Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints, Acta Cytol., 38, 335-340.
26. Bushman, E.C., Nayak, R.N. and Bushman, W. (1995) Immunohistochemical staining of ras p21: staining in benign and malignant prostate tissue, J. Urol., 153, 233-237.
27. Kok, K., Osinga, J., Schotanus, D.C., Berendsen, H.K., DeLeu, L.F.M.H. and Buys, C.H.C.M. (1989) Amplification and expression of different myc family genes in a tumour specimen and three cell lines derived from one small-cell lung cancer patient during longitudinal follow-up, Int. J. Cancer, 44, 75-78.
28. Mizukami, Y., Nonomura, A., Michigishi, T., Noguchi, M., Nakamura, S. and Hashimoto, T. (1995) Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumours: an immunohistochemical study, Anticancer Res., 15, 755-759.
29. McDonald, J.S., Jones, H., Pavelic, Z.P., Pavelic, L.J., Stambrook, P.J. and Gluckman, J.L. (1994) Immunohistochemical detection of the H-ras, K-ras and N-ras oncogenes in squamous cell carcinoma of the head and neck, J. Oral Pathol. Med., 23, 342-346.
30. Dati, C, Muraca, R., Tazartes, O., Antoniotti, S., Perroteau, I., Giai, M., Cortese, P., Sismondi, P., Saglio, G. and De Bortoli, M. (1991) C-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome, Int. J. Cancer, 47, 833-838.